When is second allogeneic HSCT for relapse of acute leukaemia an option?
Standard
When is second allogeneic HSCT for relapse of acute leukaemia an option? / Christopeit, M.
In: BONE MARROW TRANSPL, Vol. 51, No. 2, 02.2016, p. 184-5.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
Christopeit, M 2016, 'When is second allogeneic HSCT for relapse of acute leukaemia an option?', BONE MARROW TRANSPL, vol. 51, no. 2, pp. 184-5. https://doi.org/10.1038/bmt.2015.285
APA
Christopeit, M. (2016). When is second allogeneic HSCT for relapse of acute leukaemia an option? BONE MARROW TRANSPL, 51(2), 184-5. https://doi.org/10.1038/bmt.2015.285
Vancouver
Christopeit M. When is second allogeneic HSCT for relapse of acute leukaemia an option? BONE MARROW TRANSPL. 2016 Feb;51(2):184-5. https://doi.org/10.1038/bmt.2015.285
Bibtex
@article{bab82a3630d645e696b8a10ea3f79aae,
title = "When is second allogeneic HSCT for relapse of acute leukaemia an option?",
author = "M Christopeit",
note = "Comment",
year = "2016",
month = feb,
doi = "10.1038/bmt.2015.285",
language = "English",
volume = "51",
pages = "184--5",
journal = "BONE MARROW TRANSPL",
issn = "0268-3369",
publisher = "NATURE PUBLISHING GROUP",
number = "2",
}
RIS
TY - JOUR
T1 - When is second allogeneic HSCT for relapse of acute leukaemia an option?
AU - Christopeit, M
N1 - Comment
PY - 2016/2
Y1 - 2016/2
U2 - 10.1038/bmt.2015.285
DO - 10.1038/bmt.2015.285
M3 - Other (editorial matter etc.)
C2 - 26642335
VL - 51
SP - 184
EP - 185
JO - BONE MARROW TRANSPL
JF - BONE MARROW TRANSPL
SN - 0268-3369
IS - 2
ER -
